DexTech Medical
10,00 SEK
+0,20 %
DEX
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
DexTech Medical operates in biotechnology. The company conducts research and development in the field of urological oncology, where common diseases include prostate cancer. A large part of the research is carried out in collaboration with other international players, research institutes and universities. The largest operations are found in the Nordic market. The company was founded in 2004 and is headquartered in Uppsala.
Lue lisääLiikevaihto ja EBIT-%
Liikevaihto
EBIT-% (oik.)
EPS ja Osinko
EPS (oik.)
Osinko %
Pörssikalenteri
Vuosikatsaus '26
DexTech Medical's myeloma study, completed at the end of February 2026, concludes with continued strong results
DexTech Medical's Myeloma Study (ODX-MM-001), Dose Group 2 and Dose Group 3
Liity Inderesin yhteisöön
Älä jää mistään paitsi – luo käyttäjätunnus ja ota kaikki hyödyt irti Inderesin palvelusta.